Murray Junop

Dr. Murray Junop

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1999 in Cell
Verified
Journal Article
Closed access
CBChangill Ban
Changill Ban
MJMurray Junop
Murray Junop
WYWei Yang
Wei Yang

1 January 2001 in Molecular Cell
Verified
Journal Article
Closed access
MJMurray Junop
Murray Junop
GOGalina Obmolova
Galina Obmolova
KRKelly Rausch
Kelly Rausch
PHPeggy Hsieh
Peggy Hsieh
WYWei Yang
Wei Yang

27 January 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SASara N. Andres
Sara N. Andres
AVAlexandra Vergnes
Alexandra Vergnes
DRDejan Ristic
Dejan Ristic
CWClaire Wyman
Claire Wyman
MMMauro Modesti
Mauro Modesti
MJMurray Junop
Murray Junop
DNA double-strand breaks pose a significant threat to cell survival and must be repaired. In higher eukaryotes, such damage is repaired efficiently by non-homologous end joining (NHEJ). Within this pathway, XRCC4 and XLF fulfill key roles required for end joining. Using DNA-binding and -bridging assays, combined with direct visualization, we present evidence for how XRCC4–XLF complexes robustly bridge DNA molecules. This unanticipated, DNA Ligase IV-independent bridging activity by XRCC4–XLF suggests an early role for this complex during end joining, in addition to its more well-established later functions. Mutational analysis of the XRCC4–XLF C-terminal tail regions further identifies specialized functions in complex formation and interaction with DNA and DNA Ligase IV. Based on these data and the crystal structure of an extended protein filament of XRCC4–XLF at 3.94 Å, a model for XRCC4–XLF complex function in NHEJ is presented.

25 March 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JBJennifer Baysarowich
Jennifer Baysarowich
KKKalinka Koteva
Kalinka Koteva
DHDonald W. Hughes
Donald W. Hughes
LELinda Ejim
Linda Ejim
EGEmma Griffiths
Emma Griffiths
GWGerard D. Wright
Gerard D. Wright
The rifamycin antibiotic rifampin is important for the treatment of tuberculosis and infections caused by multidrug-resistant Staphylococcus aureus . Recent iterations of the rifampin core structure have resulted in new drugs and drug candidates for the treatment of a much broader range of infectious diseases. This expanded use of rifamycin antibiotics has the potential to select for increased resistance. One poorly characterized mechanism of resistance is through Arr enzymes that catalyze ADP-ribosylation of rifamycins. We find that genes encoding predicted Arr enzymes are widely distributed in the genomes of pathogenic and nonpathogenic bacteria. Biochemical analysis of three representative Arr enzymes from environmental and pathogenic bacterial sources shows that these have equally efficient drug resistance capacity in vitro and in vivo . The 3D structure of one of these orthologues from Mycobacterium smegmatis was determined and reveals structural homology with ADP-ribosyltransferases important in eukaryotic biology, including poly(ADP-ribose) polymerases (PARPs) and bacterial toxins, despite no significant amino acid sequence homology with these proteins. This work highlights the extent of the rifamycin resistome in microbial genera with the potential to negatively impact the expanded use of this class of antibiotic.

1 December 2007 in Molecular Cell
Verified
Journal Article
Closed access
SASara N. Andres
Sara N. Andres
MMMauro Modesti
Mauro Modesti
CTChun J. Tsai
Chun J. Tsai
GCGilbert Chu
Gilbert Chu
MJMurray Junop
Murray Junop

1 January 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YNYlan Nguyen
Ylan Nguyen
SSSeiji Sugiman-Marangos
Seiji Sugiman-Marangos
HHHanjeong Harvey
Hanjeong Harvey
SBStephanie D. Bell
Stephanie D. Bell
CCCarmen Lynn Charlton
Carmen Lynn Charlton
LBLori L. Burrows
Lori L. Burrows
Type IV pili (T4P) contain hundreds of major subunits, but minor subunits are also required for assembly and function. Here we show that Pseudomonas aeruginosa minor pilins prime pilus assembly and traffic the pilus-associated adhesin and anti-retraction protein, PilY1, to the cell surface. PilV, PilW and PilX require PilY1 for inclusion in surface pili and vice versa, suggestive of complex formation. PilE requires PilVWXY1 for inclusion, suggesting that it binds a novel interface created by two or more components. FimU is incorporated independently of the others and is proposed to couple the putative minor pilin-PilY1 complex to the major subunit. The production of small amounts of T4P by a mutant lacking the minor pilin operon was traced to expression of minor pseudopilins from the P. aeruginosa type II secretion (T2S) system, showing that under retraction-deficient conditions, T2S minor subunits can prime T4P assembly. Deletion of all minor subunits abrogated pilus assembly. In a strain lacking the minor pseudopilins, PilVWXY1 and either FimU or PilE comprised the minimal set of components required for pilus assembly. Supporting functional conservation of T2S and T4P minor components, our 1.4 Å crystal structure of FimU revealed striking architectural similarity to its T2S ortholog GspH, despite minimal sequence identity. We propose that PilVWXY1 form a priming complex for assembly, and that PilE and FimU together stably couple the complex to the major subunit. Trafficking of the anti-retraction factor PilY1 to the cell surface allows for production of pili of sufficient length to support adherence and motility.